Sinemet CR is a prescription medication that is used to treat the symptoms of Parkinson’s disease. It is a combination of two drugs: carbidopa and levodopa. Carbidopa helps to reduce the amount of levodopa that is broken down in the body, while levodopa helps to improve muscle control. Together, these two drugs can help to reduce the symptoms of Parkinson’s disease.
Sinemet CR is used to treat the symptoms of Parkinson’s disease, such as shakiness, stiffness, and difficulty with movement. It can also be used to help improve the quality of life of people with Parkinson’s disease. It is important to note that Sinemet CR does not cure Parkinson’s disease. It only helps to reduce the symptoms.
The most common side effects of Sinemet CR include nausea, vomiting, dizziness, drowsiness, and headache. Other side effects may include dry mouth, constipation, and confusion. If any of these side effects become severe or do not go away, it is important to contact a doctor.
Sinemet CR is a combination of two active ingredients: carbidopa and levodopa. Carbidopa is a decarboxylase inhibitor and levodopa is an amino acid. Other synonyms for Sinemet CR include Carbidopa/Levodopa, Carbidopa/Levodopa CR, and Sinemet CR.
It is important to take Sinemet CR exactly as prescribed by a doctor. It is important to follow all directions on the prescription label and to take the medication at the same time every day. It is also important to talk to a doctor before stopping or starting any medications, including Sinemet CR.
Sinemet CR can be an effective treatment for the symptoms of Parkinson’s disease. It is important to talk to a doctor about the potential benefits and side effects of Sinemet CR before beginning treatment.
References:
1. Sinemet CR (carbidopa and levodopa) extended-release tablets. (2020). Retrieved November 17, 2020, from https://www.drugs.com/sinemet-cr.html
2. Parkinson’s disease (PD) treatment. (2020). Retrieved November 17, 2020, from https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/diagnosis-treatment/drc-20376055